ORCHARD THERAPEUTICS PLC's ticker is ORTX and the CUSIP is 68570P101. A total of 76 filers reported holding ORCHARD THERAPEUTICS PLC in Q3 2020. The put-call ratio across all filers is 4.09 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $11,261,000 | -31.5% | 2,740,000 | 0.0% | 0.01% | -38.5% |
| Q2 2020 | $16,440,000 | -20.3% | 2,740,000 | 0.0% | 0.01% | -40.9% |
| Q1 2020 | $20,632,000 | -45.2% | 2,740,000 | 0.0% | 0.02% | -38.9% |
| Q4 2019 | $37,675,000 | +242.8% | 2,740,000 | +196.2% | 0.04% | +200.0% |
| Q3 2019 | $10,989,000 | -15.1% | 925,000 | 0.0% | 0.01% | -14.3% |
| Q2 2019 | $12,941,000 | -21.8% | 925,000 | 0.0% | 0.01% | -22.2% |
| Q1 2019 | $16,539,000 | +13.7% | 925,000 | 0.0% | 0.02% | -5.3% |
| Q4 2018 | $14,550,000 | – | 925,000 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |